Expands specialty and plasma capabilities to support hospitals, clinics and alternative sites of care nationwide

January 26, 2026 – Shreveport, La. — Morris & Dickson (“M&D”), the nation’s largest independent wholesale and specialty pharmaceutical distributor, today announced the successful completion of the acquisition of Prodigy Health, a specialty pharmaceutical distribution and services company. The transaction strengthens Morris & Dickson’s specialty portfolio and expands access to plasma-derived therapies, while ensuring continuity, compliance and uninterrupted service for healthcare providers nationwide.

The addition of Prodigy Health’s capabilities enhances Morris & Dickson’s ability to support hospitals, specialty pharmacies, clinics, infusion centers and alternative sites of care as demand for specialty and plasma therapies continues to grow. For manufacturers, the combination creates a broader, independent distribution platform with expanded reach, disciplined specialty capabilities and a compliance-first operating model.

“This transaction reflects our long-term commitment to specialty distribution and alternative sites of care,” said Jody Hatcher, chief executive officer of Morris & Dickson. “Our focus is on expanding access to critical therapies while preserving continuity for customers and operating with regulatory integrity that is consistent with our independent, customer-first values.”

“This is a meaningful step forward in our specialty strategy,” said Layne Martin, head of specialty at Morris & Dickson. “By bringing Prodigy Health’s purpose-built plasma and specialty expertise into the Morris & Dickson family, we are strengthening our ability to support complex therapies while maintaining the service and compliance our customers expect. Our immediate focus is disciplined execution and personalized customer support.”

As part of the transaction, Morris & Dickson will begin a phased integration process using a structured transition services model consistent with industry-specific best practices and applicable regulatory requirements. Operating as ProdigyMD, this approach is designed to maintain stability, allowing customers and manufacturers to benefit from expanded capabilities without disruption.

For customers, this means uninterrupted ordering, fulfillment and support while Morris & Dickson works to integrate Prodigy Health’s plasma and specialty tools to make them available to its broader customer base.

For manufacturers, this transaction expands access to a broader, independent distribution platform with the scale and specialty focus required to support complex therapies.

“By combining Morris & Dickson’s national reach with Prodigy Health’s specialty and plasma expertise, we are creating a reliable channel that helps manufacturers reach diverse sites of care while maintaining the service levels and regulatory integrity they expect,” said Jason Hanks, chief commercial officer of Morris & Dickson.

Effective immediately, Prodigy Health employees will become part of the Morris & Dickson family.

About Morris & Dickson
Morris & Dickson is the industry’s largest independent full-line and specialty pharmaceutical distributor with a singular focus on reliable, next-day delivery of drugs and related products to health systems, independent and specialty pharmacies, specialty clinics and infusion centers, and alternative care facilities. Serving pharmacies since 1841, Morris & Dickson continues to grow to meet customers’ needs with a comprehensive inventory of over 35,000 SKUs and a state-of-the-art, 12-acre automated distribution center, located in Louisiana. M&D plans to open a second distribution center designed to support its national and specialty growth in early 2026, located in Olive Branch, MS.  www.morrisdickson.com

About Prodigy Health
Prodigy Health is a specialty pharmaceutical distributor established in 2001 in Austin, TX. Prodigy Health is an independent, privately held organization that delivers the right solutions for its customers, emphasizing personalized service, cutting-edge technology, and trusted partnerships. The company’s dedication to efficiency, reliability, and patient-centric values has led to exceptional growth and ongoing success in markets across the United States. www.prodigyhealth.com

For inquiries:

Cassandra Johnson
SVP, Marketing & Communications
CJohnson@morrisdickson.com
214-288-5471